Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 1,240,000 shares, a growth of 21.6% from the March 15th total of 1,020,000 shares. Based on an average daily volume of 369,100 shares, the short-interest ratio […]
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 699,400 shares, a growth of 53.6% from the December 31st total of 455,200 shares. Approximately 1.8% of the company’s stock are short sold. Based on an […]